Literature DB >> 11697684

Intrinsic and extrinsic psychosis in Parkinson's disease.

E C Wolters1.   

Abstract

Direct and indirect signs and symptoms of Parkinson's disease are a major cause of disability in the elderly. Intrinsic symptoms comprise not only the well-known clinical hallmarks of this disease with motor behavioral abnormalities, such as bradykinesia, hypokinesia, rigidity and tremor, but also autonomic failure with orthostatic hypotension, urinal incontinence and impotence as well as non-motor behavioral abnormalities: mental dysfunction characterized by mood disorders, cognitive dysfunction and, sporadically, delusions and hallucinations. These symptoms are caused by a progressive abnormal degeneration of the dopamine (DA) producing cells in the substantia nigra (SN) and ventral tegmentum area (VTA) in combination with an interindividual fluctuating degree of decay in the noradrenergic (locus coeruleus), cholinergic forebrain (nucleus basalis of Meynert) and serotoninergic (dorsal raphe nuclei) systems. Extrinsic symptoms, induced by pharmacotherapy, mainly manifest with (un)predictable motor response fluctuations and dopaminomimetic psychosis. Psychological and psychiatric symptoms in Parkinson's disease (PD) are important predictors of the patient's quality of life. As these symptoms are potentially treatable, identification is of major clinical importance both for the patients and their caregivers and may enable to maintain Parkinson's disease patients at home for a longer period.

Entities:  

Mesh:

Year:  2001        PMID: 11697684     DOI: 10.1007/pl00007822

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

Review 1.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Progress Regarding Parkinson's Disease Psychosis: It's No Illusion.

Authors:  Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2016-08-11

Review 4.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

Review 5.  Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.

Authors:  Eduardo Prado; Pongsatorn Paholpak; Myha Ngo; Verna Porter; Liana G Apostolova; Rogério Marrocos; John M Ringman
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-14       Impact factor: 2.035

Review 6.  Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.

Authors:  Niyatee Samudra; Neepa Patel; Kyle B Womack; Pravin Khemani; Shilpa Chitnis
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

Review 7.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

Review 9.  Management of non-motor complications in Parkinson's disease.

Authors:  Ken-ichi Fujimoto
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

Review 10.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.